Agriculture
Global Fumonisins Immunoaffinity Columns (IAC) Market Research Report 2025
- May 12, 25
- ID: 234145
- Pages: 123
- Figures: 125
- Views: 12
The global market for Fumonisins Immunoaffinity Columns (IAC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Fumonisins Immunoaffinity Columns (IACs) are specialized chromatographic columns used for the extraction and purification of fumonisins from various samples. Fumonisins are a group of mycotoxins produced primarily by the fungi Fusarium verticillioides and Fusarium proliferatum. They commonly contaminate maize (corn) and related products.
North American market for Fumonisins Immunoaffinity Columns (IAC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fumonisins Immunoaffinity Columns (IAC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fumonisins Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisins Immunoaffinity Columns (IAC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisins Immunoaffinity Columns (IAC).
The Fumonisins Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fumonisins Immunoaffinity Columns (IAC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fumonisins Immunoaffinity Columns (IAC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
by Type
80% Below
80-90%
91-100%
100% Above
by Application
Grains
Feed
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fumonisins Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Fumonisins Immunoaffinity Columns (IAC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Fumonisins Immunoaffinity Columns (IAC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Fumonisins Immunoaffinity Columns (IACs) are specialized chromatographic columns used for the extraction and purification of fumonisins from various samples. Fumonisins are a group of mycotoxins produced primarily by the fungi Fusarium verticillioides and Fusarium proliferatum. They commonly contaminate maize (corn) and related products.
North American market for Fumonisins Immunoaffinity Columns (IAC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fumonisins Immunoaffinity Columns (IAC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fumonisins Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisins Immunoaffinity Columns (IAC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisins Immunoaffinity Columns (IAC).
The Fumonisins Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fumonisins Immunoaffinity Columns (IAC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fumonisins Immunoaffinity Columns (IAC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
by Type
80% Below
80-90%
91-100%
100% Above
by Application
Grains
Feed
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fumonisins Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Fumonisins Immunoaffinity Columns (IAC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Fumonisins Immunoaffinity Columns (IAC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Fumonisins Immunoaffinity Columns (IAC) Market Overview
1.1 Product Definition
1.2 Fumonisins Immunoaffinity Columns (IAC) by Type
1.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 80% Below
1.2.3 80-90%
1.2.4 91-100%
1.2.5 100% Above
1.3 Fumonisins Immunoaffinity Columns (IAC) by Application
1.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Grains
1.3.3 Feed
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Manufacturers (2020-2025)
2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Fumonisins Immunoaffinity Columns (IAC), Industry Ranking, 2023 VS 2024
2.4 Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Product Offered and Application
2.8 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Date of Enter into This Industry
2.9 Fumonisins Immunoaffinity Columns (IAC) Market Competitive Situation and Trends
2.9.1 Fumonisins Immunoaffinity Columns (IAC) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Fumonisins Immunoaffinity Columns (IAC) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Fumonisins Immunoaffinity Columns (IAC) Production by Region
3.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region (2020-2031)
3.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Fumonisins Immunoaffinity Columns (IAC) by Region (2026-2031)
3.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Fumonisins Immunoaffinity Columns (IAC) Production Volume by Region (2020-2031)
3.4.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Fumonisins Immunoaffinity Columns (IAC) by Region (2026-2031)
3.5 Global Fumonisins Immunoaffinity Columns (IAC) Market Price Analysis by Region (2020-2025)
3.6 Global Fumonisins Immunoaffinity Columns (IAC) Production and Value, Year-over-Year Growth
3.6.1 North America Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
4 Fumonisins Immunoaffinity Columns (IAC) Consumption by Region
4.1 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2031)
4.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025)
4.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2020-2031)
5.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2020-2025)
5.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2026-2031)
5.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2020-2031)
5.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2020-2031)
5.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2020-2025)
5.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2026-2031)
5.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2020-2031)
5.3 Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2020-2031)
6.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2020-2025)
6.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2026-2031)
6.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2020-2031)
6.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2020-2031)
6.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2020-2025)
6.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2026-2031)
6.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2020-2031)
6.3 Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Company Information
7.1.2 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.1.3 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Gold Standard Diagnostics Horsham Main Business and Markets Served
7.1.5 Gold Standard Diagnostics Horsham Recent Developments/Updates
7.2 LCTech
7.2.1 LCTech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.2.2 LCTech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.2.3 LCTech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 LCTech Main Business and Markets Served
7.2.5 LCTech Recent Developments/Updates
7.3 Shimadzu
7.3.1 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Company Information
7.3.2 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.3.3 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shimadzu Main Business and Markets Served
7.3.5 Shimadzu Recent Developments/Updates
7.4 Biotez Berlin
7.4.1 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Company Information
7.4.2 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.4.3 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Biotez Berlin Main Business and Markets Served
7.4.5 Biotez Berlin Recent Developments/Updates
7.5 PerkinElmer
7.5.1 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Company Information
7.5.2 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.5.3 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 PerkinElmer Main Business and Markets Served
7.5.5 PerkinElmer Recent Developments/Updates
7.6 VICAM
7.6.1 VICAM Fumonisins Immunoaffinity Columns (IAC) Company Information
7.6.2 VICAM Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.6.3 VICAM Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 VICAM Main Business and Markets Served
7.6.5 VICAM Recent Developments/Updates
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.7.2 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.7.3 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Ring Biotechnology Main Business and Markets Served
7.7.5 Ring Biotechnology Recent Developments/Updates
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Company Information
7.8.2 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.8.3 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 R-Biopharm AG Main Business and Markets Served
7.8.5 R-Biopharm AG Recent Developments/Updates
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Company Information
7.9.2 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.9.3 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.9.4 CHROMATIFIC Main Business and Markets Served
7.9.5 CHROMATIFIC Recent Developments/Updates
7.10 Neogen
7.10.1 Neogen Fumonisins Immunoaffinity Columns (IAC) Company Information
7.10.2 Neogen Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.10.3 Neogen Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Neogen Main Business and Markets Served
7.10.5 Neogen Recent Developments/Updates
7.11 Shandong Meizheng Bio-Tech
7.11.1 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.11.2 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.11.3 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shandong Meizheng Bio-Tech Main Business and Markets Served
7.11.5 Shandong Meizheng Bio-Tech Recent Developments/Updates
7.12 Pribolab
7.12.1 Pribolab Fumonisins Immunoaffinity Columns (IAC) Company Information
7.12.2 Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.12.3 Pribolab Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Pribolab Main Business and Markets Served
7.12.5 Pribolab Recent Developments/Updates
7.13 Jiangsu Suwei Micro-Biology Research
7.13.1 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Company Information
7.13.2 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.13.3 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Jiangsu Suwei Micro-Biology Research Main Business and Markets Served
7.13.5 Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
7.14 Shandong Lvdu Bio-Sciences & Technology
7.14.1 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.14.2 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.14.3 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Shandong Lvdu Bio-Sciences & Technology Main Business and Markets Served
7.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
7.15 Jiangsu Wisdom Engineering & Technology
7.15.1 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.15.2 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.15.3 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jiangsu Wisdom Engineering & Technology Main Business and Markets Served
7.15.5 Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
7.16 BIOCOMMA
7.16.1 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Company Information
7.16.2 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.16.3 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.16.4 BIOCOMMA Main Business and Markets Served
7.16.5 BIOCOMMA Recent Developments/Updates
7.17 Femdetection
7.17.1 Femdetection Fumonisins Immunoaffinity Columns (IAC) Company Information
7.17.2 Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.17.3 Femdetection Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Femdetection Main Business and Markets Served
7.17.5 Femdetection Recent Developments/Updates
7.18 Wuhan Huamei Wisherkon Biotech
7.18.1 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.18.2 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.18.3 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Wuhan Huamei Wisherkon Biotech Main Business and Markets Served
7.18.5 Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
7.19 Changsha Huaxue Biological Technology
7.19.1 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.19.2 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.19.3 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Changsha Huaxue Biological Technology Main Business and Markets Served
7.19.5 Changsha Huaxue Biological Technology Recent Developments/Updates
7.20 Anavo
7.20.1 Anavo Fumonisins Immunoaffinity Columns (IAC) Company Information
7.20.2 Anavo Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.20.3 Anavo Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Anavo Main Business and Markets Served
7.20.5 Anavo Recent Developments/Updates
7.21 Shandong Vnya Bio-technology
7.21.1 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.21.2 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.21.3 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Shandong Vnya Bio-technology Main Business and Markets Served
7.21.5 Shandong Vnya Bio-technology Recent Developments/Updates
7.22 Guanyibio
7.22.1 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Company Information
7.22.2 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.22.3 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.22.4 Guanyibio Main Business and Markets Served
7.22.5 Guanyibio Recent Developments/Updates
7.23 Prufunglab
7.23.1 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Company Information
7.23.2 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.23.3 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.23.4 Prufunglab Main Business and Markets Served
7.23.5 Prufunglab Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Fumonisins Immunoaffinity Columns (IAC) Industry Chain Analysis
8.2 Fumonisins Immunoaffinity Columns (IAC) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Fumonisins Immunoaffinity Columns (IAC) Production Mode & Process Analysis
8.4 Fumonisins Immunoaffinity Columns (IAC) Sales and Marketing
8.4.1 Fumonisins Immunoaffinity Columns (IAC) Sales Channels
8.4.2 Fumonisins Immunoaffinity Columns (IAC) Distributors
8.5 Fumonisins Immunoaffinity Columns (IAC) Customer Analysis
9 Fumonisins Immunoaffinity Columns (IAC) Market Dynamics
9.1 Fumonisins Immunoaffinity Columns (IAC) Industry Trends
9.2 Fumonisins Immunoaffinity Columns (IAC) Market Drivers
9.3 Fumonisins Immunoaffinity Columns (IAC) Market Challenges
9.4 Fumonisins Immunoaffinity Columns (IAC) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Fumonisins Immunoaffinity Columns (IAC) by Type
1.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 80% Below
1.2.3 80-90%
1.2.4 91-100%
1.2.5 100% Above
1.3 Fumonisins Immunoaffinity Columns (IAC) by Application
1.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Grains
1.3.3 Feed
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Manufacturers (2020-2025)
2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Fumonisins Immunoaffinity Columns (IAC), Industry Ranking, 2023 VS 2024
2.4 Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Product Offered and Application
2.8 Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Date of Enter into This Industry
2.9 Fumonisins Immunoaffinity Columns (IAC) Market Competitive Situation and Trends
2.9.1 Fumonisins Immunoaffinity Columns (IAC) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Fumonisins Immunoaffinity Columns (IAC) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Fumonisins Immunoaffinity Columns (IAC) Production by Region
3.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region (2020-2031)
3.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Fumonisins Immunoaffinity Columns (IAC) by Region (2026-2031)
3.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Fumonisins Immunoaffinity Columns (IAC) Production Volume by Region (2020-2031)
3.4.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Fumonisins Immunoaffinity Columns (IAC) by Region (2026-2031)
3.5 Global Fumonisins Immunoaffinity Columns (IAC) Market Price Analysis by Region (2020-2025)
3.6 Global Fumonisins Immunoaffinity Columns (IAC) Production and Value, Year-over-Year Growth
3.6.1 North America Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Fumonisins Immunoaffinity Columns (IAC) Production Value Estimates and Forecasts (2020-2031)
4 Fumonisins Immunoaffinity Columns (IAC) Consumption by Region
4.1 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2031)
4.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025)
4.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2020-2031)
5.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2020-2025)
5.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Production by Type (2026-2031)
5.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2020-2031)
5.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2020-2031)
5.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2020-2025)
5.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Type (2026-2031)
5.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2020-2031)
5.3 Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2020-2031)
6.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2020-2025)
6.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Production by Application (2026-2031)
6.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2020-2031)
6.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2020-2031)
6.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2020-2025)
6.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Application (2026-2031)
6.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2020-2031)
6.3 Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Company Information
7.1.2 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.1.3 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Gold Standard Diagnostics Horsham Main Business and Markets Served
7.1.5 Gold Standard Diagnostics Horsham Recent Developments/Updates
7.2 LCTech
7.2.1 LCTech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.2.2 LCTech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.2.3 LCTech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 LCTech Main Business and Markets Served
7.2.5 LCTech Recent Developments/Updates
7.3 Shimadzu
7.3.1 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Company Information
7.3.2 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.3.3 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shimadzu Main Business and Markets Served
7.3.5 Shimadzu Recent Developments/Updates
7.4 Biotez Berlin
7.4.1 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Company Information
7.4.2 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.4.3 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Biotez Berlin Main Business and Markets Served
7.4.5 Biotez Berlin Recent Developments/Updates
7.5 PerkinElmer
7.5.1 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Company Information
7.5.2 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.5.3 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 PerkinElmer Main Business and Markets Served
7.5.5 PerkinElmer Recent Developments/Updates
7.6 VICAM
7.6.1 VICAM Fumonisins Immunoaffinity Columns (IAC) Company Information
7.6.2 VICAM Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.6.3 VICAM Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 VICAM Main Business and Markets Served
7.6.5 VICAM Recent Developments/Updates
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.7.2 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.7.3 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Ring Biotechnology Main Business and Markets Served
7.7.5 Ring Biotechnology Recent Developments/Updates
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Company Information
7.8.2 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.8.3 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 R-Biopharm AG Main Business and Markets Served
7.8.5 R-Biopharm AG Recent Developments/Updates
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Company Information
7.9.2 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.9.3 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.9.4 CHROMATIFIC Main Business and Markets Served
7.9.5 CHROMATIFIC Recent Developments/Updates
7.10 Neogen
7.10.1 Neogen Fumonisins Immunoaffinity Columns (IAC) Company Information
7.10.2 Neogen Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.10.3 Neogen Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Neogen Main Business and Markets Served
7.10.5 Neogen Recent Developments/Updates
7.11 Shandong Meizheng Bio-Tech
7.11.1 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.11.2 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.11.3 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shandong Meizheng Bio-Tech Main Business and Markets Served
7.11.5 Shandong Meizheng Bio-Tech Recent Developments/Updates
7.12 Pribolab
7.12.1 Pribolab Fumonisins Immunoaffinity Columns (IAC) Company Information
7.12.2 Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.12.3 Pribolab Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Pribolab Main Business and Markets Served
7.12.5 Pribolab Recent Developments/Updates
7.13 Jiangsu Suwei Micro-Biology Research
7.13.1 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Company Information
7.13.2 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.13.3 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Jiangsu Suwei Micro-Biology Research Main Business and Markets Served
7.13.5 Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
7.14 Shandong Lvdu Bio-Sciences & Technology
7.14.1 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.14.2 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.14.3 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Shandong Lvdu Bio-Sciences & Technology Main Business and Markets Served
7.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
7.15 Jiangsu Wisdom Engineering & Technology
7.15.1 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.15.2 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.15.3 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jiangsu Wisdom Engineering & Technology Main Business and Markets Served
7.15.5 Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
7.16 BIOCOMMA
7.16.1 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Company Information
7.16.2 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.16.3 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.16.4 BIOCOMMA Main Business and Markets Served
7.16.5 BIOCOMMA Recent Developments/Updates
7.17 Femdetection
7.17.1 Femdetection Fumonisins Immunoaffinity Columns (IAC) Company Information
7.17.2 Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.17.3 Femdetection Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Femdetection Main Business and Markets Served
7.17.5 Femdetection Recent Developments/Updates
7.18 Wuhan Huamei Wisherkon Biotech
7.18.1 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Company Information
7.18.2 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.18.3 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Wuhan Huamei Wisherkon Biotech Main Business and Markets Served
7.18.5 Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
7.19 Changsha Huaxue Biological Technology
7.19.1 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.19.2 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.19.3 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Changsha Huaxue Biological Technology Main Business and Markets Served
7.19.5 Changsha Huaxue Biological Technology Recent Developments/Updates
7.20 Anavo
7.20.1 Anavo Fumonisins Immunoaffinity Columns (IAC) Company Information
7.20.2 Anavo Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.20.3 Anavo Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Anavo Main Business and Markets Served
7.20.5 Anavo Recent Developments/Updates
7.21 Shandong Vnya Bio-technology
7.21.1 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Company Information
7.21.2 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.21.3 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Shandong Vnya Bio-technology Main Business and Markets Served
7.21.5 Shandong Vnya Bio-technology Recent Developments/Updates
7.22 Guanyibio
7.22.1 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Company Information
7.22.2 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.22.3 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.22.4 Guanyibio Main Business and Markets Served
7.22.5 Guanyibio Recent Developments/Updates
7.23 Prufunglab
7.23.1 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Company Information
7.23.2 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Portfolio
7.23.3 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Production, Value, Price and Gross Margin (2020-2025)
7.23.4 Prufunglab Main Business and Markets Served
7.23.5 Prufunglab Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Fumonisins Immunoaffinity Columns (IAC) Industry Chain Analysis
8.2 Fumonisins Immunoaffinity Columns (IAC) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Fumonisins Immunoaffinity Columns (IAC) Production Mode & Process Analysis
8.4 Fumonisins Immunoaffinity Columns (IAC) Sales and Marketing
8.4.1 Fumonisins Immunoaffinity Columns (IAC) Sales Channels
8.4.2 Fumonisins Immunoaffinity Columns (IAC) Distributors
8.5 Fumonisins Immunoaffinity Columns (IAC) Customer Analysis
9 Fumonisins Immunoaffinity Columns (IAC) Market Dynamics
9.1 Fumonisins Immunoaffinity Columns (IAC) Industry Trends
9.2 Fumonisins Immunoaffinity Columns (IAC) Market Drivers
9.3 Fumonisins Immunoaffinity Columns (IAC) Market Challenges
9.4 Fumonisins Immunoaffinity Columns (IAC) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity (K Units) by Manufacturers in 2024
Table 4. Global Fumonisins Immunoaffinity Columns (IAC) Production by Manufacturers (2020-2025) & (K Units)
Table 5. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Manufacturers (2020-2025)
Table 6. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Fumonisins Immunoaffinity Columns (IAC), Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Fumonisins Immunoaffinity Columns (IAC) as of 2024)
Table 10. Global Market Fumonisins Immunoaffinity Columns (IAC) Average Price by Manufacturers (US$/Unit) & (2020-2025)
Table 11. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Product Offered and Application
Table 13. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Date of Enter into This Industry
Table 14. Global Fumonisins Immunoaffinity Columns (IAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Region (2020-2025)
Table 19. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Fumonisins Immunoaffinity Columns (IAC) Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Region (2020-2025)
Table 23. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Region (2020-2025)
Table 24. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) Forecast by Region (2026-2031)
Table 25. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share Forecast by Region (2026-2031)
Table 26. Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price (US$/Unit) by Region (2020-2025)
Table 27. Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price (US$/Unit) by Region (2026-2031)
Table 28. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 29. Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025) & (K Units)
Table 30. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region (2020-2025)
Table 31. Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption by Region (2026-2031) & (K Units)
Table 32. Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 34. North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 35. North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 36. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 37. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 38. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 39. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 40. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025) & (K Units)
Table 41. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2026-2031) & (K Units)
Table 42. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 43. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 44. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 45. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Type (2020-2025)
Table 46. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Type (2026-2031)
Table 47. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2020-2025)
Table 48. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2026-2031)
Table 49. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2020-2025)
Table 52. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2026-2031)
Table 53. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2020-2025)
Table 54. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2026-2031)
Table 55. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Application (2020-2025)
Table 56. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Application (2026-2031)
Table 57. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2020-2025)
Table 58. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2026-2031)
Table 59. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2020-2025)
Table 62. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2026-2031)
Table 63. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2020-2025)
Table 64. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2026-2031)
Table 65. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 66. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 67. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 68. Gold Standard Diagnostics Horsham Main Business and Markets Served
Table 69. Gold Standard Diagnostics Horsham Recent Developments/Updates
Table 70. LCTech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 71. LCTech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 72. LCTech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. LCTech Main Business and Markets Served
Table 74. LCTech Recent Developments/Updates
Table 75. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 76. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 77. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Shimadzu Main Business and Markets Served
Table 79. Shimadzu Recent Developments/Updates
Table 80. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 81. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 82. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biotez Berlin Main Business and Markets Served
Table 84. Biotez Berlin Recent Developments/Updates
Table 85. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 86. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 87. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. PerkinElmer Main Business and Markets Served
Table 89. PerkinElmer Recent Developments/Updates
Table 90. VICAM Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 91. VICAM Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 92. VICAM Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. VICAM Main Business and Markets Served
Table 94. VICAM Recent Developments/Updates
Table 95. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 96. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 97. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Ring Biotechnology Main Business and Markets Served
Table 99. Ring Biotechnology Recent Developments/Updates
Table 100. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 101. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 102. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. R-Biopharm AG Main Business and Markets Served
Table 104. R-Biopharm AG Recent Developments/Updates
Table 105. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 106. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 107. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. CHROMATIFIC Main Business and Markets Served
Table 109. CHROMATIFIC Recent Developments/Updates
Table 110. Neogen Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 111. Neogen Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 112. Neogen Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Neogen Main Business and Markets Served
Table 114. Neogen Recent Developments/Updates
Table 115. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 116. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 117. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shandong Meizheng Bio-Tech Main Business and Markets Served
Table 119. Shandong Meizheng Bio-Tech Recent Developments/Updates
Table 120. Pribolab Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 121. Pribolab Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 122. Pribolab Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Pribolab Main Business and Markets Served
Table 124. Pribolab Recent Developments/Updates
Table 125. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 126. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 127. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Jiangsu Suwei Micro-Biology Research Main Business and Markets Served
Table 129. Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
Table 130. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 131. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 132. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shandong Lvdu Bio-Sciences & Technology Main Business and Markets Served
Table 134. Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
Table 135. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 136. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 137. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jiangsu Wisdom Engineering & Technology Main Business and Markets Served
Table 139. Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
Table 140. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 141. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 142. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. BIOCOMMA Main Business and Markets Served
Table 144. BIOCOMMA Recent Developments/Updates
Table 145. Femdetection Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 146. Femdetection Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 147. Femdetection Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Femdetection Main Business and Markets Served
Table 149. Femdetection Recent Developments/Updates
Table 150. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 151. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 152. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Wuhan Huamei Wisherkon Biotech Main Business and Markets Served
Table 154. Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
Table 155. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 156. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 157. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Changsha Huaxue Biological Technology Main Business and Markets Served
Table 159. Changsha Huaxue Biological Technology Recent Developments/Updates
Table 160. Anavo Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 161. Anavo Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 162. Anavo Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Anavo Main Business and Markets Served
Table 164. Anavo Recent Developments/Updates
Table 165. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 166. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 167. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Shandong Vnya Bio-technology Main Business and Markets Served
Table 169. Shandong Vnya Bio-technology Recent Developments/Updates
Table 170. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 171. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 172. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Guanyibio Main Business and Markets Served
Table 174. Guanyibio Recent Developments/Updates
Table 175. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 176. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 177. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Prufunglab Main Business and Markets Served
Table 179. Prufunglab Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Fumonisins Immunoaffinity Columns (IAC) Distributors List
Table 183. Fumonisins Immunoaffinity Columns (IAC) Customers List
Table 184. Fumonisins Immunoaffinity Columns (IAC) Market Trends
Table 185. Fumonisins Immunoaffinity Columns (IAC) Market Drivers
Table 186. Fumonisins Immunoaffinity Columns (IAC) Market Challenges
Table 187. Fumonisins Immunoaffinity Columns (IAC) Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Fumonisins Immunoaffinity Columns (IAC)
Figure 2. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Type: 2024 VS 2031
Figure 4. 80% Below Product Picture
Figure 5. 80-90% Product Picture
Figure 6. 91-100% Product Picture
Figure 7. 100% Above Product Picture
Figure 8. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Application, (US$ Million) & (2020-2031)
Figure 9. Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Application: 2024 VS 2031
Figure 10. Grains
Figure 11. Feed
Figure 12. Others
Figure 13. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) & (2020-2031)
Figure 15. Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity (K Units) & (2020-2031)
Figure 16. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) & (2020-2031)
Figure 17. Global Fumonisins Immunoaffinity Columns (IAC) Average Price (US$/Unit) & (2020-2031)
Figure 18. Fumonisins Immunoaffinity Columns (IAC) Report Years Considered
Figure 19. Fumonisins Immunoaffinity Columns (IAC) Production Share by Manufacturers in 2024
Figure 20. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Share by Manufacturers (2024)
Figure 21. Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2024
Figure 23. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Fumonisins Immunoaffinity Columns (IAC) Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 26. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 32. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 34. North America Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 36. Canada Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 37. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 38. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 39. Germany Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 40. France Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 41. U.K. Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 42. Italy Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 43. Russia Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 44. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 45. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region (2020-2031)
Figure 46. China Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 47. Japan Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 48. South Korea Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 49. China Taiwan Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 50. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 51. India Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 52. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 53. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 55. Brazil Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 56. Turkey Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 57. GCC Countries Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 58. Global Production Market Share of Fumonisins Immunoaffinity Columns (IAC) by Type (2020-2031)
Figure 59. Global Production Value Market Share of Fumonisins Immunoaffinity Columns (IAC) by Type (2020-2031)
Figure 60. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Production Market Share of Fumonisins Immunoaffinity Columns (IAC) by Application (2020-2031)
Figure 62. Global Production Value Market Share of Fumonisins Immunoaffinity Columns (IAC) by Application (2020-2031)
Figure 63. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2020-2031)
Figure 64. Fumonisins Immunoaffinity Columns (IAC) Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Table 1. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity (K Units) by Manufacturers in 2024
Table 4. Global Fumonisins Immunoaffinity Columns (IAC) Production by Manufacturers (2020-2025) & (K Units)
Table 5. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Manufacturers (2020-2025)
Table 6. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Fumonisins Immunoaffinity Columns (IAC), Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Fumonisins Immunoaffinity Columns (IAC) as of 2024)
Table 10. Global Market Fumonisins Immunoaffinity Columns (IAC) Average Price by Manufacturers (US$/Unit) & (2020-2025)
Table 11. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Product Offered and Application
Table 13. Global Key Manufacturers of Fumonisins Immunoaffinity Columns (IAC), Date of Enter into This Industry
Table 14. Global Fumonisins Immunoaffinity Columns (IAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Region (2020-2025)
Table 19. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Fumonisins Immunoaffinity Columns (IAC) Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Region (2020-2025)
Table 23. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Region (2020-2025)
Table 24. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) Forecast by Region (2026-2031)
Table 25. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share Forecast by Region (2026-2031)
Table 26. Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price (US$/Unit) by Region (2020-2025)
Table 27. Global Fumonisins Immunoaffinity Columns (IAC) Market Average Price (US$/Unit) by Region (2026-2031)
Table 28. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 29. Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025) & (K Units)
Table 30. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region (2020-2025)
Table 31. Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption by Region (2026-2031) & (K Units)
Table 32. Global Fumonisins Immunoaffinity Columns (IAC) Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 34. North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 35. North America Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 36. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 37. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 38. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 39. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 40. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2020-2025) & (K Units)
Table 41. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption by Region (2026-2031) & (K Units)
Table 42. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 43. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2020-2025) & (K Units)
Table 44. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption by Country (2026-2031) & (K Units)
Table 45. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Type (2020-2025)
Table 46. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Type (2026-2031)
Table 47. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2020-2025)
Table 48. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Type (2026-2031)
Table 49. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2020-2025)
Table 52. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Type (2026-2031)
Table 53. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2020-2025)
Table 54. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2026-2031)
Table 55. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Application (2020-2025)
Table 56. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) by Application (2026-2031)
Table 57. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2020-2025)
Table 58. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Application (2026-2031)
Table 59. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2020-2025)
Table 62. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Application (2026-2031)
Table 63. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2020-2025)
Table 64. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2026-2031)
Table 65. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 66. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 67. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 68. Gold Standard Diagnostics Horsham Main Business and Markets Served
Table 69. Gold Standard Diagnostics Horsham Recent Developments/Updates
Table 70. LCTech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 71. LCTech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 72. LCTech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. LCTech Main Business and Markets Served
Table 74. LCTech Recent Developments/Updates
Table 75. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 76. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 77. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Shimadzu Main Business and Markets Served
Table 79. Shimadzu Recent Developments/Updates
Table 80. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 81. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 82. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biotez Berlin Main Business and Markets Served
Table 84. Biotez Berlin Recent Developments/Updates
Table 85. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 86. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 87. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. PerkinElmer Main Business and Markets Served
Table 89. PerkinElmer Recent Developments/Updates
Table 90. VICAM Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 91. VICAM Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 92. VICAM Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. VICAM Main Business and Markets Served
Table 94. VICAM Recent Developments/Updates
Table 95. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 96. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 97. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Ring Biotechnology Main Business and Markets Served
Table 99. Ring Biotechnology Recent Developments/Updates
Table 100. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 101. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 102. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. R-Biopharm AG Main Business and Markets Served
Table 104. R-Biopharm AG Recent Developments/Updates
Table 105. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 106. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 107. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. CHROMATIFIC Main Business and Markets Served
Table 109. CHROMATIFIC Recent Developments/Updates
Table 110. Neogen Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 111. Neogen Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 112. Neogen Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Neogen Main Business and Markets Served
Table 114. Neogen Recent Developments/Updates
Table 115. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 116. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 117. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shandong Meizheng Bio-Tech Main Business and Markets Served
Table 119. Shandong Meizheng Bio-Tech Recent Developments/Updates
Table 120. Pribolab Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 121. Pribolab Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 122. Pribolab Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Pribolab Main Business and Markets Served
Table 124. Pribolab Recent Developments/Updates
Table 125. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 126. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 127. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Jiangsu Suwei Micro-Biology Research Main Business and Markets Served
Table 129. Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
Table 130. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 131. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 132. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shandong Lvdu Bio-Sciences & Technology Main Business and Markets Served
Table 134. Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
Table 135. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 136. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 137. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jiangsu Wisdom Engineering & Technology Main Business and Markets Served
Table 139. Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
Table 140. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 141. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 142. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. BIOCOMMA Main Business and Markets Served
Table 144. BIOCOMMA Recent Developments/Updates
Table 145. Femdetection Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 146. Femdetection Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 147. Femdetection Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Femdetection Main Business and Markets Served
Table 149. Femdetection Recent Developments/Updates
Table 150. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 151. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 152. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Wuhan Huamei Wisherkon Biotech Main Business and Markets Served
Table 154. Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
Table 155. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 156. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 157. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Changsha Huaxue Biological Technology Main Business and Markets Served
Table 159. Changsha Huaxue Biological Technology Recent Developments/Updates
Table 160. Anavo Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 161. Anavo Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 162. Anavo Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Anavo Main Business and Markets Served
Table 164. Anavo Recent Developments/Updates
Table 165. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 166. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 167. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Shandong Vnya Bio-technology Main Business and Markets Served
Table 169. Shandong Vnya Bio-technology Recent Developments/Updates
Table 170. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 171. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 172. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Guanyibio Main Business and Markets Served
Table 174. Guanyibio Recent Developments/Updates
Table 175. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Company Information
Table 176. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Specification and Application
Table 177. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Prufunglab Main Business and Markets Served
Table 179. Prufunglab Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Fumonisins Immunoaffinity Columns (IAC) Distributors List
Table 183. Fumonisins Immunoaffinity Columns (IAC) Customers List
Table 184. Fumonisins Immunoaffinity Columns (IAC) Market Trends
Table 185. Fumonisins Immunoaffinity Columns (IAC) Market Drivers
Table 186. Fumonisins Immunoaffinity Columns (IAC) Market Challenges
Table 187. Fumonisins Immunoaffinity Columns (IAC) Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Fumonisins Immunoaffinity Columns (IAC)
Figure 2. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Type: 2024 VS 2031
Figure 4. 80% Below Product Picture
Figure 5. 80-90% Product Picture
Figure 6. 91-100% Product Picture
Figure 7. 100% Above Product Picture
Figure 8. Global Fumonisins Immunoaffinity Columns (IAC) Market Value by Application, (US$ Million) & (2020-2031)
Figure 9. Global Fumonisins Immunoaffinity Columns (IAC) Market Share by Application: 2024 VS 2031
Figure 10. Grains
Figure 11. Feed
Figure 12. Others
Figure 13. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) & (2020-2031)
Figure 15. Global Fumonisins Immunoaffinity Columns (IAC) Production Capacity (K Units) & (2020-2031)
Figure 16. Global Fumonisins Immunoaffinity Columns (IAC) Production (K Units) & (2020-2031)
Figure 17. Global Fumonisins Immunoaffinity Columns (IAC) Average Price (US$/Unit) & (2020-2031)
Figure 18. Fumonisins Immunoaffinity Columns (IAC) Report Years Considered
Figure 19. Fumonisins Immunoaffinity Columns (IAC) Production Share by Manufacturers in 2024
Figure 20. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Share by Manufacturers (2024)
Figure 21. Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2024
Figure 23. Global Fumonisins Immunoaffinity Columns (IAC) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Fumonisins Immunoaffinity Columns (IAC) Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Fumonisins Immunoaffinity Columns (IAC) Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 26. Global Fumonisins Immunoaffinity Columns (IAC) Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Fumonisins Immunoaffinity Columns (IAC) Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Fumonisins Immunoaffinity Columns (IAC) Consumption by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 32. Global Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 34. North America Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 36. Canada Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 37. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 38. Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 39. Germany Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 40. France Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 41. U.K. Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 42. Italy Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 43. Russia Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 44. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 45. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Region (2020-2031)
Figure 46. China Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 47. Japan Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 48. South Korea Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 49. China Taiwan Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 50. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 51. India Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 52. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 53. Latin America, Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 55. Brazil Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 56. Turkey Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 57. GCC Countries Fumonisins Immunoaffinity Columns (IAC) Consumption and Growth Rate (2020-2031) & (K Units)
Figure 58. Global Production Market Share of Fumonisins Immunoaffinity Columns (IAC) by Type (2020-2031)
Figure 59. Global Production Value Market Share of Fumonisins Immunoaffinity Columns (IAC) by Type (2020-2031)
Figure 60. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Production Market Share of Fumonisins Immunoaffinity Columns (IAC) by Application (2020-2031)
Figure 62. Global Production Value Market Share of Fumonisins Immunoaffinity Columns (IAC) by Application (2020-2031)
Figure 63. Global Fumonisins Immunoaffinity Columns (IAC) Price (US$/Unit) by Application (2020-2031)
Figure 64. Fumonisins Immunoaffinity Columns (IAC) Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Music Streaming Service Market Research Report 2025
Sep 18, 25
Global Project Collaboration Software Market Research Report 2025
Sep 18, 25
Global Predictive Analytics Software Market Research Report 2025
Sep 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232